Give Kiwis a fighting chance
Bring CAR T-cell therapy to New Zealand – and into the lives of those we love.
Jessica just donated $1
Xander just donated $2.10
CAR T-cell therapy is transforming cancer treatment across the world. But in New Zealand it remains out of reach for most patients.
While lives are being saved elsewhere, New Zealanders are missing out because bringing advanced treatments like CAR T-cell therapy to New Zealand is complex and costly.
Currently, people must travel thousands of kilometres overseas to receive it. Many cannot afford to. Some never even get the chance.
You can help change that.
At the Malaghan Institute, we believe every Kiwi should have access to advanced cancer therapies – right here at home.
In 2019, the Malaghan Institute launched New Zealand’s first clinical trial of CAR T-cell therapy. This one-off treatment works by reprogramming a patient’s own immune cells to seek out and destroy their cancer, harnessing the power of their own immune system to fight back.
Our phase 1 trial proved what’s possible: doors were opened, hope was sparked – and New Zealanders who had run out of options were part of something ground-breaking.
Now we are in phase 2, treating more patients earlier in their cancer journey, building the capability and gathering the evidence needed to embed CAR T-cell therapy as a standard of care in our public health system.
This is our final push towards Kiwis getting access to this life-changing treatment here at home, without the crushing costs or barriers.
But we can only make it possible with your support.
Help us finish what we started in bringing our homegrown breakthrough from the lab to New Zealanders who need it.
Let's give all New Zealanders the same chance as Kirsty.
When Kirsty was diagnosed with non-Hodgkin lymphoma, her life turned upside down. Multiple rounds of chemotherapy failed. Her partner, Mick, had recently passed away from cancer. She was now fighting for her life while trying to care for her young son, Sam.
With no remaining treatment options in the public system, Kirsty was accepted into the Malaghan Institute’s ENABLE phase 1 CAR T-cell trial - the first of its kind in New Zealand.
“It’s incredible to think this happened here in New Zealand. This treatment gave me time with Sam. I just hope more people get the chance I did — without needing to go overseas or fight to be part of a trial.” - Kirsty, participant in the Malaghan Institute's CAR T-cell phase 1 trial.
Kirsty’s story offers real hope. It also highlights why continued progress in treatments like CAR T-cell therapy matters, so that more people who may benefit can access it.
“This isn’t just a process change; this is a step change. It’s about democratising a cutting-edge cancer therapy that New Zealanders deserve to have access to and reducing inequities in cancer outcomes.”
-
PROFESSOR GRAHAM LE GROS
New Zealand for life-changing treatment.
Treatments like CAR T-cell therapy are fundamentally changing cancer treatment.
Watch this video to see the potent cancer-killing effects of CAR T-cells.
The biggest barrier to better cancer treatments in New Zealand isn’t the science - it’s the funding.
To learn more about how you can join this ground-breaking effort please contact:
An-Li TheronPhilanthropy Specialist
E: atheron@malaghan.org.nz
Account Name: The Malaghan Institute of Medical Research
Account Number: 06-0507-0052635-30
Your reference: First name & Last name or supporter ID
If you donate via direct deposit, please email us with your details so we can send you a receipt.